Cargando…
A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species
Dysregulation of osteoclast-osteoblast balance, resulting in abnormal bone remodeling, is responsible for postmenopausal osteoporosis (PMOP) or other secondary forms of osteoporosis. We demonstrated that dictamnine (DIC), a novel RANKL-targeted furoquinoline alkaloid, inhibits osteoclastogenesis by...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652067/ https://www.ncbi.nlm.nih.gov/pubmed/36388169 http://dx.doi.org/10.1155/2022/5982014 |
_version_ | 1784828384804601856 |
---|---|
author | Wong, Puiian Lv, Zheng Li, Jinglan Wei, Qiushi Xu, LiangLiang Fang, Bin Luo, Yiwen He, Mincong |
author_facet | Wong, Puiian Lv, Zheng Li, Jinglan Wei, Qiushi Xu, LiangLiang Fang, Bin Luo, Yiwen He, Mincong |
author_sort | Wong, Puiian |
collection | PubMed |
description | Dysregulation of osteoclast-osteoblast balance, resulting in abnormal bone remodeling, is responsible for postmenopausal osteoporosis (PMOP) or other secondary forms of osteoporosis. We demonstrated that dictamnine (DIC), a novel RANKL-targeted furoquinoline alkaloid, inhibits osteoclastogenesis by facilitating the activities of reactive oxygen species (ROS), NF-κB, and NFATc1 in vitro and prevents the development of OVX-induced osteoporosis mouse models in vivo. Methods. The docking mechanism of DIC and RANKL was initially identified by protein–ligand molecular docking. RNA sequencing was performed and analyzed to reveal the potential mechanism and signaling pathway of the antiosteoporosis effects of DIC. To verify the sequencing results, we examined the impact of DIC on RANKL-induced osteoclast differentiation, bone resorption, F-actin ring production, ROS generation, and NF-κB activation in osteoclasts in vitro. Moreover, a luciferase assay was performed to determine the binding and transcriptional activity of Nrf2 and NF-κB. The in vivo efficacy of DIC was assessed with an ovariectomy- (OVX-) induced osteoporosis model, which was analyzed using micro-CT and bone histomorphometry. Results. The molecular docking results indicated that DIC could bind particularly to RANKL. RNA-seq confirmed that DIC could regulate the osteoclast-related pathway. DIC suppressed osteoclastogenesis, bone resorption, F-actin belt formation, osteoclast-specific gene expression, and ROS activity by preventing NFATc1 expression and affecting NF-κB signaling pathways in vitro. The luciferase assay showed that DIC not only suppressed the activity of Nrf2 but also contributed to the combination of Nrf2 and NF-κB. Our in vivo study indicated that DIC protects against OVX-induced osteoporosis and preserves bone volume by inhibiting osteoclast activity and function. Conclusions. DIC can ameliorate osteoclast formation and OVX-induced osteoporosis and therefore is a potential therapeutic treatment for osteoporosis. |
format | Online Article Text |
id | pubmed-9652067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-96520672022-11-15 A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species Wong, Puiian Lv, Zheng Li, Jinglan Wei, Qiushi Xu, LiangLiang Fang, Bin Luo, Yiwen He, Mincong Oxid Med Cell Longev Research Article Dysregulation of osteoclast-osteoblast balance, resulting in abnormal bone remodeling, is responsible for postmenopausal osteoporosis (PMOP) or other secondary forms of osteoporosis. We demonstrated that dictamnine (DIC), a novel RANKL-targeted furoquinoline alkaloid, inhibits osteoclastogenesis by facilitating the activities of reactive oxygen species (ROS), NF-κB, and NFATc1 in vitro and prevents the development of OVX-induced osteoporosis mouse models in vivo. Methods. The docking mechanism of DIC and RANKL was initially identified by protein–ligand molecular docking. RNA sequencing was performed and analyzed to reveal the potential mechanism and signaling pathway of the antiosteoporosis effects of DIC. To verify the sequencing results, we examined the impact of DIC on RANKL-induced osteoclast differentiation, bone resorption, F-actin ring production, ROS generation, and NF-κB activation in osteoclasts in vitro. Moreover, a luciferase assay was performed to determine the binding and transcriptional activity of Nrf2 and NF-κB. The in vivo efficacy of DIC was assessed with an ovariectomy- (OVX-) induced osteoporosis model, which was analyzed using micro-CT and bone histomorphometry. Results. The molecular docking results indicated that DIC could bind particularly to RANKL. RNA-seq confirmed that DIC could regulate the osteoclast-related pathway. DIC suppressed osteoclastogenesis, bone resorption, F-actin belt formation, osteoclast-specific gene expression, and ROS activity by preventing NFATc1 expression and affecting NF-κB signaling pathways in vitro. The luciferase assay showed that DIC not only suppressed the activity of Nrf2 but also contributed to the combination of Nrf2 and NF-κB. Our in vivo study indicated that DIC protects against OVX-induced osteoporosis and preserves bone volume by inhibiting osteoclast activity and function. Conclusions. DIC can ameliorate osteoclast formation and OVX-induced osteoporosis and therefore is a potential therapeutic treatment for osteoporosis. Hindawi 2022-11-04 /pmc/articles/PMC9652067/ /pubmed/36388169 http://dx.doi.org/10.1155/2022/5982014 Text en Copyright © 2022 Puiian Wong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wong, Puiian Lv, Zheng Li, Jinglan Wei, Qiushi Xu, LiangLiang Fang, Bin Luo, Yiwen He, Mincong A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species |
title | A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species |
title_full | A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species |
title_fullStr | A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species |
title_full_unstemmed | A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species |
title_short | A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species |
title_sort | novel rankl-targeted furoquinoline alkaloid ameliorates bone loss in ovariectomized osteoporosis through inhibiting the nf-κb signal pathway and reducing reactive oxygen species |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652067/ https://www.ncbi.nlm.nih.gov/pubmed/36388169 http://dx.doi.org/10.1155/2022/5982014 |
work_keys_str_mv | AT wongpuiian anovelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT lvzheng anovelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT lijinglan anovelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT weiqiushi anovelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT xuliangliang anovelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT fangbin anovelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT luoyiwen anovelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT hemincong anovelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT wongpuiian novelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT lvzheng novelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT lijinglan novelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT weiqiushi novelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT xuliangliang novelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT fangbin novelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT luoyiwen novelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies AT hemincong novelrankltargetedfuroquinolinealkaloidamelioratesbonelossinovariectomizedosteoporosisthroughinhibitingthenfkbsignalpathwayandreducingreactiveoxygenspecies |